EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia

Ayla Tourkmani, Turki Alharbi, Osama Abdelhay, Hesham Al khashan, Al Joharah Al Obaikan, Aboud Alaboud, Ahmed Bakhiet, Hala Alqahtani, Saad Al Battal, Nawaf Abanami

Clinical Audit · 2017

DOI: 10.2147/ca.s122952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Audit, 2017. Verfasst von Ayla Tourkmani und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Tourkmani, A., Alharbi, T., Abdelhay, O., khashan, H. A., Obaikan, A. J. A., Alaboud, A., Bakhiet, A., Alqahtani, H., Battal, S. A., & Abanami, N. (2017). Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia. Clinical Audit. https://doi.org/10.2147/ca.s122952

Vancouver

Tourkmani A, Alharbi T, Abdelhay O, khashan HA, Obaikan AJA, Alaboud A, et al. Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia. Clinical Audit. 2017. doi:10.2147/ca.s122952

BibTeX
@article{Tourkmani2017,
  author = {Tourkmani, Ayla and Alharbi, Turki and Abdelhay, Osama and khashan, Hesham Al and Obaikan, Al Joharah Al and Alaboud, Aboud and Bakhiet, Ahmed and Alqahtani, Hala and Battal, Saad Al and Abanami, Nawaf},
  title = {Clinical audit for the adherence to safety monitoring for pioglitazone use in patients with type 2 diabetes in the Al-Wazarat primary care center, Saudi Arabia},
  journal = {Clinical Audit},
  year = {2017},
  doi = {10.2147/ca.s122952}
}
Kostenlos starten →